Information Technology & Services - , ,
The staggering clinical trial failure rate of experimental drugs indicates thatdespite huge investments in novel technologies over the years, productivitygains in the pharmaceutical industry remained elusive. It is therefore generallyagreed that the current biopharma model is unsustainable and disruptiveapproaches are needed to remedy the status quo.The biopharmaceuticalindustry is looking towards artificial intelligence (AI) to speed up drugdiscovery, cut R&D costs, decrease failure rates in drug trials and eventuallycreate improved medicines.There is a solution.Emergent System Intelligence (ESA) designs trailblazing new approaches in life science product development using clinical & scientific expertise combined with the next evolution of artificial intelligence - Emergent Intelligence technology.
Gmail
Google Apps